Pharmacokinetics and pharmacodynamics of newer fluoroquinolones

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
G E Stein

Abstract

Newer fluoroquinolones currently under development have excellent pharmacokinetic profiles, and several parameters have been improved compared with those of their predecessors. These compounds are well absorbed, have large volumes of distribution, and distribute into most tissues at concentrations equal to or greater than those observed in serum. Moreover, these newer agents have long serum elimination half-lives that allow for once-daily dosing. With the exception of complexes with multivalent cations that retard absorption, there is a relative lack of clinically significant drug-drug interactions with these antimicrobials. Increased microbiological potency against several important pathogens, along with an enhanced pharmacokinetic profile, will make these newer fluoroquinolones preferable over older compounds for the treatment of a variety of infections.

Citations

Sep 28, 1998·Biochimica Et Biophysica Acta·D C Hooper
Jun 17, 2000·International Journal of Antimicrobial Agents·H García OvandoC Errecalde
May 4, 1999·The Journal of Antimicrobial Chemotherapy·I W KlimbergR M Echols
Dec 17, 2008·Antimicrobial Agents and Chemotherapy·Jossy van den BoogaardRob E Aarnoutse
Feb 7, 2001·Clinical Microbiology Reviews·A Alvarez-BarrientosM Sánchez-Pérez
Feb 21, 2009·Journal of Translational Medicine·Hossam M Ashour, Amany El-Sharif
Mar 23, 2010·World Journal of Emergency Surgery : WJES·Massimo Sartelli
Jan 15, 2011·World Journal of Emergency Surgery : WJES·Massimo SartelliErnest E Moore
Jan 9, 2013·World Journal of Emergency Surgery : WJES·Massimo SartelliTomohisa Shoko
May 1, 2001·Clinical Pharmacokinetics·A AminimanizaniR Jelliffe
Nov 25, 2014·Expert Review of Respiratory Medicine·Chris StockmannCatherine M T Sherwin
Mar 23, 2012·Expert Opinion on Drug Metabolism & Toxicology·Aditi MulgaonkarDouglas H Sweet
Sep 24, 2015·Critical Reviews in Analytical Chemistry·Lucas Chierentin, Hérida Regina Nunes Salgado
May 7, 2002·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·P Moreillon, J M Entenza
Aug 5, 2000·Mayo Clinic Proceedings·R C Walker
May 7, 1999·The American Journal of Medicine·C R Gregg
Mar 28, 2006·Regulatory Toxicology and Pharmacology : RTP·Agnès Perrin-GuyomardMary Bartholomew
Mar 31, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Muhammad NisarRashid Ali
Mar 5, 2015·Clinical Pharmacokinetics·Chris StockmannCatherine M T Sherwin
Sep 6, 2003·The Journal of Pharmacy and Pharmacology·Chiho Ono, Makoto Tanaka
Oct 3, 2002·The Journal of Pharmacy and Pharmacology·Hiroyoshi HayakawaAkira Tsuji
Aug 5, 2000·The Annals of Pharmacotherapy·A A Alghasham, M C Nahata
Dec 11, 1999·The Journal of Antimicrobial Chemotherapy·J M EntenzaP Moreillon
Mar 7, 2000·The Journal of Antimicrobial Chemotherapy·M M Sánchez-RecioA Sánchez-Navarro
Jul 26, 2005·Burns : Journal of the International Society for Burn Injuries·Ronan Le FlochAlain Pilorget
Dec 18, 2013·Therapeutic Advances in Respiratory Disease·Chris StockmannMichael G Spigarelli
Jul 28, 2012·European Journal of Mass Spectrometry·Mirjana CvijovicPredrag Djurdjevic
Oct 20, 2001·Pharmacotherapy·D N Fish
Dec 5, 2006·Expert Review of Anti-infective Therapy·Joseph P LynchGeorge G Zhanel
May 23, 2013·Dalton Transactions : an International Journal of Inorganic Chemistry·Nadia E A El-Gamel
Apr 3, 2020·Expert Opinion on Drug Safety·Carla BastidaAntoni Torres
Mar 29, 2000·Australian Veterinary Journal·R D Walker
Oct 23, 2003·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Hiroyoshi HayakawaAkira Tsuji
Dec 31, 1998·Antimicrobial Agents and Chemotherapy·J M EntenzaP Moreillon

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
S M Finegold
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
S Nachnani, G T Clark
International Journal of Antimicrobial Agents
S Hedges, C Svanborg
© 2021 Meta ULC. All rights reserved